SCHEMBL3217546

SCHEMBL3217546

CC(C)c1ccccc1NN

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.53
GRIN2D O15399 1/20 0.49
GRIN3B O60391 1/20 0.49
GRIN1 Q05586 1/20 0.49
GRIN2A Q12879 1/20 0.49
GRIN2B Q13224 1/20 0.49
GRIN2C Q14957 1/20 0.49
GRIN3A Q8TCU5 1/20 0.49
SIGMAR1 Q99720 1/20 0.49
POLB P06746 1/20 0.48
GABRA1 P14867 3/20 0.44
GABRB2 P47870 2/20 0.44
NPC1 O15118 1/20 0.42
MAPT P10636 1/20 0.42
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA12 O43570 2/20 0.41
CA9 Q16790 2/20 0.41
GABRG2 P18507 2/20 0.41
GABRB3 P28472 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31130182 0.98 L3MBTL1 (0.52) L3MBTL1GRIN2DGRIN3BGRIN1GRIN2A
Hydrochloric Acid SCHEMBL4935247 0.98 L3MBTL1 (0.52) L3MBTL1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL17714332 0.82 GRIN2D (0.39) L3MBTL1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL21563551 0.80 GABRA1 (0.41) L3MBTL1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL3958491 0.80 L3MBTL1 (0.57) L3MBTL1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL9764653 0.80 L3MBTL1 (0.57) L3MBTL1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL30147688 0.79 L3MBTL1 (0.35) L3MBTL1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL21598452 0.79 L3MBTL1 (0.35) L3MBTL1GRIN2DGRIN3BGRIN1GRIN2A
Hydrochloric Acid SCHEMBL18172016 0.79 HTR2A (0.41) L3MBTL1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL2737240 0.78 L3MBTL1 (0.55) L3MBTL1GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115707334-A Method for rubber regeneration A·A·斯拉涅夫斯基 2023-02-17 CN disclosed
CN-112409203-B Method for simultaneously synthesizing phenylhydrazine salt and pyruvic acid or glyoxylic acid 帕潘纳(北京)科技有限公司 2022-10-25 CN disclosed
CN-112409203-A Method for simultaneously synthesizing phenylhydrazine salt and pyruvic acid or glyoxylic acid 帕潘纳(北京)科技有限公司 2021-02-26 CN disclosed
US-20190119251-A1 AMIDE-SUBSTITUTED ARYLTRIAZOLE DERIVATIVES AND USES THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2019-04-25 US disclosed
EP-3452468-A1 AMIDE-SUBSTITUTED ARYLTRIAZOLE DERIVATIVES AND USES THEREOF Bayer Pharma Aktiengesellschaft (DE) 2019-03-13 EP disclosed
CN-105985464-B Solid catalytic component for olefin polymerization and catalyst thereof 中国石油天然气股份有限公司 2018-04-03 CN disclosed
WO-2017191105-A1 AMIDE-SUBSTITUTED ARYLTRIAZOLE DERIVATIVES AND USES THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-11-09 WO disclosed
US-9227917-B2 Amine-containing lipidoids and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2016-01-05 US disclosed
US-20100240630-A1 COMPOUNDS AND THERAPEUTIC USES THEREOF Myriad Pharmaceuticals, Inc.. (US) 2010-09-23 US disclosed
US-20100240630-A1 COMPOUNDS AND THERAPEUTIC USES THEREOF Myriad Pharmaceuticals, Inc.. (US) 2010-09-23 US disclosed
US-20090054607-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same HANAOKA HIDENORI 2009-02-26 US disclosed
US-7439379-B2 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL CO., LTD. (JP) 2008-10-21 US disclosed
US-20080153828-A1 Imidazopyridazine Compounds ELI LILLY AND COMPANY 2008-06-26 US disclosed
EP-1879896-A1 IMIDAZOPYRIDAZINE COMPOUNDS ELI LILLY AND COMPANY (US) 2008-01-23 EP disclosed
WO-2006107784-A1 IMIDAZOPYRIDAZINE COMPOUNDS ELI LILLY AND COMPANY (US) 2006-10-12 WO disclosed
US-20040242410-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-12-02 US disclosed
EP-1426379-A1 TRANSITION METAL COMPLEX,CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME Sumitomo Chemical Company, Limited (JP) 2004-06-09 EP disclosed
EP-0275667-B1 3-HETERO-SUBSTITUTED-N-BENZYL-INDOLES MERCK FROSST CANADA INC. (CA) 1992-03-18 EP disclosed
US-4128560-A Tricyclic alkylamine derivatives AYERST MCKENNA & HARRISON LTD. (CA) 1978-12-05 US disclosed
US-4057559-A ANTIINFLAMMATORY AGENTS AMERICAN HOME PRODUCTS CORPORATION (US) 1977-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054607-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same C1R, C1S, AP1M1 L3MBTL1 1838/4885GRIN2D 3431/4885GRIN3B 2469/4885
US-20100240630-A1 COMPOUNDS AND THERAPEUTIC USES THEREOF HAVCR2, FURIN, SARS1 L3MBTL1 2822/4885GRIN2D 4124/4885GRIN3B 1792/4885
US-20080153828-A1 Imidazopyridazine Compounds CRHR1, CRH, CRHR2 L3MBTL1 4787/4885GRIN2D 147/4885GRIN3B 130/4885
US-20190119251-A1 AMIDE-SUBSTITUTED ARYLTRIAZOLE DERIVATIVES AND USES THEREOF AADAC, NAT1, GLS L3MBTL1 2728/4885GRIN2D 2887/4885GRIN3B 2495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.